Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
Titel:
Outcomes by line of therapy and programmed death ligand 1 expression in patients with advanced melanoma treated with pembrolizumab or ipilimumab in KEYNOTE-006: A randomised clinical trial
Auteur:
Carlino, Matteo S. Long, Georgina V. Schadendorf, Dirk Robert, Caroline Ribas, Antoni Richtig, Erika Nyakas, Marta Caglevic, Christian Tarhini, Ahmed Blank, Christian Hoeller, Christoph Bar-Sela, Gil Barrow, Catherine Wolter, Pascal Zhou, Honghong Emancipator, Kenneth Jensen, Erin H. Ebbinghaus, Scot Ibrahim, Nageatte Daud, Adil